It has been hypothesized that hepcidin may slow or prevent the mobilization of iron from macrophages and lead to an increased cardiovascular disease risk, such as atherosclerosis and other cardiovascular disease such as Kawasaki disease [13–15]. This evidence concerns the gene HAMP and atherosclerosis.